These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36962873)

  • 1. Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India.
    Song D; Pallas SW; Shimpi R; Ramaswamy N; Haldar P; Harvey P; Bhatnagar P; Katkar A; Jayaprasad N; Kunwar A; Bahl S; Morgan W; Hutubessy R; Date K; Mogasale V
    PLOS Glob Public Health; 2023; 3(1):e0001396. PubMed ID: 36962873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Date K; Shimpi R; Luby S; N R; Haldar P; Katkar A; Wannemuehler K; Mogasale V; Pallas S; Song D; Kunwar A; Loharikar A; Yewale V; Ahmed D; Horng L; Wilhelm E; Bahl S; Harvey P; Dutta S; Bhatnagar P
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S172-S178. PubMed ID: 32725235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Vaccine Safety After the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Longley AT; Date K; Luby SP; Bhatnagar P; Bentsi-Enchill AD; Goyal V; Shimpi R; Katkar A; Yewale V; Jayaprasad N; Horng L; Kunwar A; Harvey P; Haldar P; Dutta S; Gidudu JF
    Clin Infect Dis; 2021 Aug; 73(4):e927-e933. PubMed ID: 33502453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
    Hoffman SA; LeBoa C; Date K; Haldar P; Harvey P; Shimpi R; An Q; Zhang C; Jayaprasad N; Horng L; Fagerli K; Borhade P; Daruwalla S; Dharmapalan D; Gavhane J; Joshi S; Rai R; Rathod V; Shetty K; Warrier DS; Yadav S; Chakraborty D; Bahl S; Katkar A; Kunwar A; Yewale V; Andrews JR; Bhatnagar P; Dutta S; Luby SP
    Clin Infect Dis; 2023 Jul; 77(1):138-144. PubMed ID: 36947143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
    Debellut F; Mkisi R; Masoo V; Chisema M; Mwagomba D; Mtenje M; Limani F; Mategula D; Zimba B; Pecenka C
    Vaccine; 2022 Mar; 40(12):1741-1746. PubMed ID: 35153097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of typhoid vaccination in India.
    Chauhan AS; Kapoor I; Rana SK; Kumar D; Gupta M; John J; Kang G; Prinja S
    Vaccine; 2021 Jul; 39(30):4089-4098. PubMed ID: 34120765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine - Harare, Zimbabwe, 2019.
    Poncin M; Marembo J; Chitando P; Sreenivasan N; Makwara I; Machekanyanga Z; Nyabyenda W; Mukeredzi I; Munyanyi M; Hidle A; Chingwena F; Chigwena C; Atuhebwe P; Matzger H; Chigerwe R; Shaum A; Date K; Garone D; Chonzi P; Barak J; Phiri I; Rupfutse M; Masunda K; Gasasira A; Manangazira P
    Vaccine X; 2022 Dec; 12():100201. PubMed ID: 35983519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program.
    Baral R; Levin A; Odero C; Pecenka C; Tanko Bawa J; Antwi-Agyei KO; Amponsa-Achaino K; Chisema MN; Eddah Jalango R; Mkisi R; Gordon S; Morgan W; Muhib F
    Vaccine; 2023 Feb; 41(8):1496-1502. PubMed ID: 36710234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of seasonal influenza vaccine delivery in a pediatric demonstration project for children aged 6-23 months - Nakuru and Mombasa Counties, Kenya, 2019-2021.
    Gharpure R; Akumu AO; Dawa J; Gobin S; Adhikari BB; Lafond KE; Fischer LS; Mirieri H; Mwazighe H; Tabu C; Jalang'o R; Kamau P; Silali C; Kalani R; Oginga P; Jewa I; Njenga V; Ebama MS; Bresee JS; Njenga MK; Osoro E; Meltzer MI; Emukule GO
    Vaccine; 2023 Dec; ():. PubMed ID: 38154992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of Shanchol™ vaccine use in Lake Chilwa, Malawi.
    Ilboudo PG; Le Gargasson JB
    BMC Infect Dis; 2017 Dec; 17(1):779. PubMed ID: 29258447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
    Baral R; Levin A; Odero C; Pecenka C; Tabu C; Mwendo E; Bonsu G; Bawa J; Dadzie JF; Charo J; Antwi-Agyei KO; Amponsa-Achianou K; Jalango RE; Mkisi R; Gordon S; Mzengeza T; Morgan W; Muhib F
    PLoS One; 2021; 16(1):e0244995. PubMed ID: 33428635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    Botwright S; Holroyd T; Nanda S; Bloem P; Griffiths UK; Sidibe A; Hutubessy RCW
    PLoS One; 2017; 12(10):e0182663. PubMed ID: 29016596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incremental cost of improving immunization coverage in India through the Intensified Mission Indradhanush programme.
    Chatterjee S; Das P; Pinheiro A; Haldar P; Ray A; Brenzel L; Resch S
    Health Policy Plan; 2021 Sep; 36(8):1316-1324. PubMed ID: 33950262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool).
    Morgan W; Levin A; Hutubessy RC; Mogasale V
    Hum Vaccin Immunother; 2020 Dec; 16(12):3111-3118. PubMed ID: 32530361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions.
    Mogasale V; Ramani E; Park IY; Lee JS
    Hum Vaccin Immunother; 2017 Sep; 13(9):2017-2024. PubMed ID: 28604164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
    Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
    PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Evaluation of the Cost of Human Papilloma Virus (HPV) Vaccine Delivery In Zambia.
    Simuyemba MC; Chama-Chiliba CM; Chompola A; Sinyangwe A; Bchir A; Asiimwe G; Masiye F; Chibwesha C
    Res Sq; 2023 May; ():. PubMed ID: 37398262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low costs and opportunities for efficiency: a cost analysis of the first year of programmatic PrEP delivery in Kenya's public sector.
    Peebles K; Mugwanya KK; Irungu E; Odoyo J; Wamoni E; Morton JF; Ngure K; Bukusi EA; Mugo NR; Masyuko S; Mukui I; Baeten JM; Barnabas RV;
    BMC Health Serv Res; 2021 Aug; 21(1):823. PubMed ID: 34399736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of conducting Measles-Rubella vaccination campaign in India.
    Chatterjee S; Song D; Das P; Haldar P; Ray A; Brenzel L; Boonstoppel L; Mogasale V
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-8. PubMed ID: 34411494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.